Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

The efficacy and safety of luspatercept in patients with low-blasts myelodysplastic neoplasms in real world

Huijuan Jiang, Lijuan Li, Jia Song, Huaquan Wang, Yuhong Wu, Wen Qu, Jing Guan, Limin Xing, Guojin Wang, Hong Liu, Zonghong Shao, Rong Fu

Blood (2025) 146 (Supplement 1): 7400.

https://doi.org/10.1182/blood-2025-7400

Published: 2025

Journal Articles

Role of NK cells in immune escape in patients with classical paroxysmal nocturnal hemoglobinuria

Chaomeng Wang, Yan Yang, Wei Wang, Liyan Li, Mengting Che, Yingying Chen, Honglei Wang, Zhaoyun Liu, Lijuan Li, Hui LIU, Rong Fu

Blood (2025) 146 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2025-4664

Published: 2025

Journal Articles

S100A12-Orchestrated Macrophage-ER stress crosstalk in MDS: Mechanisms and precision therapeutic targeting

Li Zhang, Liansheng Zhang, Ting Niu, Lijuan li

Blood (2025) 146 (Supplement 1): 6769.

https://doi.org/10.1182/blood-2025-6769

Published: 2025

Journal Articles

The USP22-NAP1L1 deubiquitination axis in the pathogenesis of myelodysplastic syndromes

Lijuan Li, Jiayi Xie, Nan Song, Zhaoyun Liu, Mengjie Yuan, Hanyuan Chang

Blood (2025) 146 (Supplement 1): 2059.

https://doi.org/10.1182/blood-2025-2059

Published: 2025

Journal Articles

Efficacy and safety of romiplostim N01 combined with cyclosporine in refractory aplastic anemia patients：a multicenter phase II study

Ting Wang, Lijuan Li, Huaquan Wang, Jia Song, Hui LIU, Yihao Wang, Liyan Li, Yue Ren, Rong Fu

Blood (2025) 146 (Supplement 1): 3195.

https://doi.org/10.1182/blood-2025-3195

Published: 2025

Journal Articles

Y chromosome loss drives sex disparities in multiple myeloma by reshaping the immune landscape

Liansheng Zhang, Zuxi Feng, Lijuan li

Blood (2025) 146 (Supplement 1): 7471.

https://doi.org/10.1182/blood-2025-7471

Published: 2025

Journal Articles

The role of neutrophil extracellular traps in thrombosis of paroxysmal nocturnal hemoglobinuria

Mengting Che, Hui LIU, Yan Yang, Chaomeng Wang, Liyan Li, Honglei Wang, Yingying Chen, Zhaoyun Liu, Lijuan Li, Rong Fu

Blood (2025) 146 (Supplement 1): 1112.

https://doi.org/10.1182/blood-2025-1112

Published: 2025

Journal Articles

DARS mediated M2 polarization of tumor associated macrophages drives MPN progression

Hao xiong, hanlu zhang, Ting Niu, Lijuan li, Liansheng Zhang

Blood (2025) 146 (Supplement 1): 5006.

https://doi.org/10.1182/blood-2025-5006

Published: 2025

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Rong Fu, Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Jie Zhuo, Huijuan Jiang, Shan Gao, Yue Ren, Lijuan Li, Yihao Wang

Blood (2024) 144 (Supplement 1): 7786.

https://doi.org/10.1182/blood-2024-209056

Published: 2024

Journal Articles

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Wang Ying, Jianxiang Wang, Weihua Zhai, Erlie Jiang

Blood (2024) 144 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2024-202404

Published: 2024

Journal Articles

Efficacy and Safety of Different TPO-RAs Combined with Cyclosporine in the Treatment of NSAA

Ting Wang, Donglan Liu, Nianbin Li, Shuai Gao, Lijuan Li, Jia Song, Huaquan Wang, Rong Fu

Blood (2024) 144 (Supplement 1): 5691.

https://doi.org/10.1182/blood-2024-209539

Published: 2024

Journal Articles

Efficacy and Safety of Hetrombopag in the Treatment of Chemotherapy-Induced Thrombocytopenia in Pediatric Acute Leukemia

Chunhui Yang, Runxiu Yin, Lijuan Li, Chunyan Song, Huiyuan Li, Zugang Xiao, Shaoqin Duan, Xin Tian

Blood (2024) 144 (Supplement 1): 5422.

https://doi.org/10.1182/blood-2024-204421

Published: 2024

Journal Articles

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Weihua Zhai, Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Ying Wang, Erlie Jiang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 7073.

https://doi.org/10.1182/blood-2023-180077

Published: 2023

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Yihao Wang, Hong Yu, Yuanyuan Shao, Huijuan Jiang, Shan Gao, Lijuan Li, Rong Fu, Zonghong Shao

Blood (2022) 140 (Supplement 1): 3739–3740.

https://doi.org/10.1182/blood-2022-164677

Published: 2022

Journal Articles

Study of TIM-3 in Pathogenesis of Myelodysplastic Syndrome

Pei Liu, Zonghong Shao, MD, Lijuan Li, MD, Jinglian Tao, MD, Huaquan Wang, MD, Rong Fu, PhD

Blood (2018) 132 (Supplement 1): 4388.

https://doi.org/10.1182/blood-2018-99-114343

Published: 2018

Journal Articles

Whole-Exome Sequencing of Paroxysmal Nocturnal Hemoglobinuria

Rong Fu, PhD, Liyan LI, Hui Liu, Yun Liu, PhD, Lijuan Li, MD, Kai Ding, MD, Zonghong Shao, MD

Blood (2017) 130 (Supplement 1): 3475.

https://doi.org/10.1182/blood.V130.Suppl_1.3475.3475

Published: 2017

Journal Articles

Decreased Tim-3 Expression Level of Peripheral Blood Natural Killer Cells in Severe Aplastic Anemia

Rong Fu, MD, Xin Yuan, Chunyan Liu, Hui Liu, Yihao Wang, Tong Chen, Lijuan Li, Jia Song, Guojin Wang, Zonghong Shao, MD

Blood (2015) 126 (23): 4767.

https://doi.org/10.1182/blood.V126.23.4767.4767

Published: 2015

Journal Articles

The Dysfunction of Platelets in Paroxysmal Nocturnal Hemoglobinuria

Rong Fu, PhD, Yinping Meng, Yihao Wang, Hui Liu, Yi Liu, Lijuan Li, Shaoxue Ding, Erbao Ruan, MD, Huaquan Wang, MD, Guojin Wang, Jia Song, Zonghong Shao, MD

Blood (2015) 126 (23): 4532.

https://doi.org/10.1182/blood.V126.23.4532.4532

Published: 2015

Journal Articles

Zoledronic Acid Inhibits Cell Growth of Multiple Myeloma Cells and Shows Synergistic Antimyeloma Effects with Bortezomib Via CD38 /cADPR /Ca2+ /Ras /Pakt /NF-Kb /Pim-2 Pathway

Rong Fu, MD, Zhaoyun Liu, Hui Liu, Jia Song, Guojin Wang, Yihao Wang, Lijuan Li, Zonghong Shao, MD

Blood (2015) 126 (23): 5311.

https://doi.org/10.1182/blood.V126.23.5311.5311

Published: 2015

Journal Articles

TET2 Gene Expression in Bone Marrow Cells in Myelodysplastic Syndromes Patients and the Effect of Silencing TET2 by siRNA On Biological Characteristics of Healthy CD34+ Cells

Zonghong Shao, MD, Wei Zhang, PhD, Rong Fu, PhD, Lijuan Li, PhD, Huaquan Wang, PhD

Blood (2012) 120 (21): 4934.

https://doi.org/10.1182/blood.V120.21.4934.4934

Published: 2012

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The efficacy and safety of luspatercept in patients with low-blasts myelodysplastic neoplasms in real world

Role of NK cells in immune escape in patients with classical paroxysmal nocturnal hemoglobinuria

S100A12-Orchestrated Macrophage-ER stress crosstalk in MDS: Mechanisms and precision therapeutic targeting

The USP22-NAP1L1 deubiquitination axis in the pathogenesis of myelodysplastic syndromes

Efficacy and safety of romiplostim N01 combined with cyclosporine in refractory aplastic anemia patients：a multicenter phase II study

Y chromosome loss drives sex disparities in multiple myeloma by reshaping the immune landscape

The role of neutrophil extracellular traps in thrombosis of paroxysmal nocturnal hemoglobinuria

DARS mediated M2 polarization of tumor associated macrophages drives MPN progression

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Efficacy and Safety of Different TPO-RAs Combined with Cyclosporine in the Treatment of NSAA

Efficacy and Safety of Hetrombopag in the Treatment of Chemotherapy-Induced Thrombocytopenia in Pediatric Acute Leukemia

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Study of TIM-3 in Pathogenesis of Myelodysplastic Syndrome

Whole-Exome Sequencing of Paroxysmal Nocturnal Hemoglobinuria

Decreased Tim-3 Expression Level of Peripheral Blood Natural Killer Cells in Severe Aplastic Anemia

The Dysfunction of Platelets in Paroxysmal Nocturnal Hemoglobinuria

Zoledronic Acid Inhibits Cell Growth of Multiple Myeloma Cells and Shows Synergistic Antimyeloma Effects with Bortezomib Via CD38 /cADPR /Ca2+ /Ras /Pakt /NF-Kb /Pim-2 Pathway

TET2 Gene Expression in Bone Marrow Cells in Myelodysplastic Syndromes Patients and the Effect of Silencing TET2 by siRNA On Biological Characteristics of Healthy CD34+ Cells

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only